Nader Moniri

Professor of Biomedical Sciences, School of Medicine @Mercer University

Atlanta, GA, US
MOBILE NUMBERS
+16•••••••45

Signup · Get unlimited contacts

WORK HISTORY

Jan 2020 — Present

Professor of Biomedical Sciences, School of Medicine @Mercer University

View department →

EDUCATION

1992 — 1997

Georgia State University

B.S., Biology/Chemistry

2004 — 2006

Duke University Medical Center

Post-Doctoral Fellow, Biochemistry and Molecular Pharmacology

1999 — 2004

The University of North Carolina at Chapel Hill

Ph.D., Medicinal Chemistry

SKILLS

Cell SignalingUniversity TeachingPharmacyPharmaceutical IndustryNeurosciencePharmaceutical ResearchMedicinal ChemistryBiochemistryImmunologyAssay DevelopmentPolymerase Chain Reaction (Pcr)ElisaGel ElectrophoresisDrug DeliveryBiologyGenomicsDrug DevelopmentSignal TransductionMotivationDnaProtein ChemistryIn VitroMolecular BiologyDrug DiscoveryTeachingChemistryInfectious DiseasesIn VivoCellScientific WritingCell Based AssaysHigh Throughput ScreeningPhysiologyPharmacologyCell CultureCell BiologySds-Page

ABOUT NADER MONIRI

As Associate Dean for Research and Professor of Pharmaceutical Sciences, I serve as an educator, researcher, and academic leader committed to advancing science, scholarship, and student success.In the classroom, I teach across the biomedical and pharmaceutical sciences curriculum, including courses in physiology, pathophysiology, pharmacology, and medicinal chemistry, with content spanning musculoskeletal and pain disorders, endocrine disorders, nervous system disorders, and infectious diseases. Educating and mentoring the next generation of healthcare professionals is one of my greatest passions, and I am honored to have received numerous student- and college-bestowed teaching awards recognizing this commitment.My research centers on the biochemistry and molecular pharmacology of G protein-coupled receptors (GPCRs), integrating aspects of drug discovery and medicinal chemistry to better understand receptor function and signaling. My laboratory investigates the roles of the beta-2 adrenergic receptor and the free fatty acid receptors GPR120 (FFA4) and GPR40 (FFA1) in human health and disease, with the goal of identifying novel therapeutic strategies. Our work is currently supported by multiple NIH grants.In my administrative role, I oversee and promote research across the College of Pharmacy-spanning biomedical, pharmaceutical, clinical, and administrative sciences. I work to foster interdisciplinary collaborations, mentor faculty in research development, and steward the College’s research portfolio to support innovation and impact.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.